For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
-
Narrated by:
-
By:
About this listen
Featuring perspectives from Dr Anne Chiang, Ms Elizabeth Krueger, Ms Beth Sandy and Dr Erin Schenk, including the following topics:
- Introduction: Overview of Bispecific Antibodies (0:00)
- Biology of Small-Cell Lung Cancer (SCLC) and Review of Its Initial Management (13:37)
- Case: 63-year-old man — Ms Krueger (23:36)
- Current Role of Tarlatamab in Therapy for SCLC (33:40)
- Case: 70-year-old woman — Ms Sandy (43:41)
- Future Directions in the Management of SCLC (50:45)
- Case: 81-year-old man — Ms Krueger (1:01:24)
- Unique Considerations in SCLC Management (1:09:29)
- Case: 67-year-old woman — Ms Sandy (1:22:53)
NCPD information and select publications
What listeners say about For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.